JP2023517035A - 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 - Google Patents

間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 Download PDF

Info

Publication number
JP2023517035A
JP2023517035A JP2022553155A JP2022553155A JP2023517035A JP 2023517035 A JP2023517035 A JP 2023517035A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2023517035 A JP2023517035 A JP 2023517035A
Authority
JP
Japan
Prior art keywords
cells
subject
stem cells
mlpscs
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022553155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517035A5 (https=
Inventor
シルヴィウ・イテスク
Original Assignee
メゾブラスト・インターナショナル・エスアーエールエル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020900685A external-priority patent/AU2020900685A0/en
Application filed by メゾブラスト・インターナショナル・エスアーエールエル filed Critical メゾブラスト・インターナショナル・エスアーエールエル
Publication of JP2023517035A publication Critical patent/JP2023517035A/ja
Publication of JP2023517035A5 publication Critical patent/JP2023517035A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2022553155A 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 Pending JP2023517035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900685 2020-03-05
AU2020900685A AU2020900685A0 (en) 2020-03-05 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
PCT/EP2021/055483 WO2021176001A1 (en) 2020-03-05 2021-03-04 Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells

Publications (2)

Publication Number Publication Date
JP2023517035A true JP2023517035A (ja) 2023-04-21
JP2023517035A5 JP2023517035A5 (https=) 2024-03-13

Family

ID=74867509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022553155A Pending JP2023517035A (ja) 2020-03-05 2021-03-04 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法

Country Status (9)

Country Link
US (1) US20230293589A1 (https=)
EP (1) EP4114418A1 (https=)
JP (1) JP2023517035A (https=)
KR (1) KR20220150919A (https=)
CN (1) CN115361958A (https=)
AU (1) AU2021232614A1 (https=)
BR (1) BR112022017557A2 (https=)
CA (1) CA3170255A1 (https=)
WO (1) WO2021176001A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
SG11202004680UA (en) 2017-11-22 2020-06-29 Mesoblast Int Sarl Cellular compositions and methods of treatment i
EP4181935A1 (en) * 2020-07-20 2023-05-24 Brainstorm Cell Therapeutics Ltd. Methods and compositions for treating lung conditions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087933A1 (en) * 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
WO2018151046A1 (ja) * 2017-02-15 2018-08-23 ロート製薬株式会社 肺線維症治療剤、ｐｔｐｒｒ発現促進剤及び肺線維症治療用キット
WO2019051623A1 (es) * 2017-09-16 2019-03-21 Cells For Cells S.A. Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
EP3461884B1 (en) * 2004-03-22 2025-05-28 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN105796598A (zh) * 2014-12-29 2016-07-27 西比曼生物科技（上海）有限公司 一种用于治疗慢性阻塞性肺疾病的脂肪间充质祖细胞复合物
CN111297899A (zh) * 2020-02-21 2020-06-19 云南雅盛医疗科技有限公司 一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087933A1 (en) * 2010-10-08 2012-04-12 Samson Tom Enhanced msc preparations
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
WO2018151046A1 (ja) * 2017-02-15 2018-08-23 ロート製薬株式会社 肺線維症治療剤、ｐｔｐｒｒ発現促進剤及び肺線維症治療用キット
WO2019051623A1 (es) * 2017-09-16 2019-03-21 Cells For Cells S.A. Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BMC PUBLIC HEALTH, vol. Vol.20, Article number:6, JPN6024051413, January 2020 (2020-01-01), ISSN: 0005630920 *
CHEST, vol. 143, no. 6, JPN6024051409, 2013, pages 1590 - 1598, ISSN: 0005630918 *
ENGINEERING, vol. 6, JPN6024051411, February 2020 (2020-02-01), pages 1153 - 1161, ISSN: 0005833910 *
JOURNAL OF BIOMEDICAL SCIENCE, vol. Vol.23, Article number:76, JPN6024051412, 2016, ISSN: 0005630921 *
RESPIRATORY RESEARCH, vol. Vol.15, Article number:39, JPN6024051410, 2014, ISSN: 0005630922 *
STEM CELL RESEARCH & THERAPY, vol. 11, no. 60, JPN6025026160, 13 February 2020 (2020-02-13), pages 1 - 14, ISSN: 0005630917 *
日本職業・災害医学会会誌, vol. 62, no. 3, JPN6024051414, 2014, pages 184 - 188, ISSN: 0005630919 *

Also Published As

Publication number Publication date
US20230293589A1 (en) 2023-09-21
AU2021232614A1 (en) 2022-09-29
WO2021176001A1 (en) 2021-09-10
BR112022017557A2 (pt) 2022-12-27
EP4114418A1 (en) 2023-01-11
CA3170255A1 (en) 2021-09-10
CN115361958A (zh) 2022-11-18
KR20220150919A (ko) 2022-11-11

Similar Documents

Publication Publication Date Title
TWI698242B (zh) 利用血管母細胞產生間葉基質細胞之方法
US20130224157A1 (en) Stem cells for treating lung diseases
US20230165904A1 (en) Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
JP2023517035A (ja) 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法
JP2023517641A (ja) 炎症性腸疾患を治療するための方法ｉｉ
JP2023513847A (ja) 慢性移植片対宿主病の治療方法
JP2023517636A (ja) 炎症性腸疾患を治療するための方法ｉ
US20240197787A1 (en) Method for treating acute respiratory distress syndrome (ards) in specific patients using mesenchymal lineage precursor or stem cells
WO2023119239A1 (en) Method of treating severe graft versus host disease
CN117337184A (zh) 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240304

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250701

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250925

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260407